Brief: Nykode Therapeutics Q1 Operating Loss USD 6.5 Million
BRIEF-Nykode Therapeutics Q1 Operating Loss USD 6.5 Million May 27 (Reuters) - Nykode Therapeutics ASA NYKD.OL:
Q1 OPERATING LOSS USD 6.5 MILLION
Q1 TOTAL REVENUE AND OTHER INCOME USD 0.2 MILLION
Source text: ID:nObi4f4C6a
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026